Sinsin Pharmaceutical Co. Ltd (002800) — Cash Flow Quality Index
Sinsin Pharmaceutical Co. Ltd (002800) has a Cash Flow Quality Index of 1.37x as of September 2025. Operating cash flow of ₩4.70 Billion exceeds net income of ₩3.42 Billion, indicating high earnings quality where cash backs reported profits. Explore 002800 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sinsin Pharmaceutical Co. Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Sinsin Pharmaceutical Co. Ltd cash flow conversion.
Annual Cash Flow Quality Index for Sinsin Pharmaceutical Co. Ltd (2015–2024)
Year-by-year earnings quality comparison for Sinsin Pharmaceutical Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.24x | ₩5.94 Billion | ₩4.81 Billion | ▲ +46.0% |
| 2023 | 0.85x | ₩3.93 Billion | ₩4.65 Billion | ▼ -31.6% |
| 2022 | 1.24x | ₩5.46 Billion | ₩4.41 Billion | ▼ -75.9% |
| 2020 | 5.14x | ₩1.87 Billion | ₩362.66 Million | ▲ +344.0% |
| 2019 | -2.11x | ₩-4.51 Billion | ₩2.14 Billion | ▼ -888.4% |
| 2018 | 0.27x | ₩774.24 Million | ₩2.90 Billion | ▼ -78.9% |
| 2017 | 1.27x | ₩4.57 Billion | ₩3.60 Billion | ▲ +101.4% |
| 2016 | 0.63x | ₩2.79 Billion | ₩4.44 Billion | ▼ -53.3% |
| 2015 | 1.35x | ₩5.24 Billion | ₩3.89 Billion | — |